Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

14 structures for Q9Y262

Entry ID Method Resolution Chain Position Source
3J8B EM - L 1-515 PDB
3J8C EM - L 1-515 PDB
6FEC EM 630 A 7 1-564 PDB
6YBD EM 330 A 5 1-564 PDB
6ZMW EM 370 A 5 1-564 PDB
6ZON EM 300 A L 1-564 PDB
6ZP4 EM 290 A L 1-564 PDB
6ZVJ EM 380 A L 181-552 PDB
7A09 EM 350 A L 1-564 PDB
7QP6 EM 470 A 5 1-564 PDB
7QP7 EM 370 A 5 1-564 PDB
8OZ0 EM 350 A K 1-564 PDB
8PPL EM 265 A I5 1-564 PDB
AF-Q9Y262-F1 Predicted AlphaFoldDB

333 variants for Q9Y262

Variant ID(s) Position Change Description Diseaes Association Provenance
rs766985954
CA10226682
2 S>C No ClinGen
ExAC
gnomAD
rs766985954
CA411473847
2 S>F No ClinGen
ExAC
gnomAD
TCGA novel 3 Y>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA411473865
rs1199562373
3 Y>F No ClinGen
gnomAD
rs1482437483
CA411473857
3 Y>H No ClinGen
gnomAD
rs754308322
CA10226683
4 P>S No ClinGen
ExAC
gnomAD
CA10226685
rs765452125
5 A>G No ClinGen
ExAC
rs755402882
CA10226684
5 A>T No ClinGen
ExAC
gnomAD
rs11551389
CA324155837
7 D>G No ClinGen
Ensembl
CA411473957
rs1314308236
7 D>Y No ClinGen
TOPMed
CA10226686
rs752992953
8 Y>H No ClinGen
ExAC
gnomAD
rs777950587
CA10226688
9 E>D No ClinGen
ExAC
gnomAD
CA324155843
rs992209191
9 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA411474022
rs992209191
9 E>Q Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA10226689
rs751635601
10 S>F No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 11 E>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs757244575
CA10226690
11 E>K No ClinGen
ExAC
rs1291657146
CA411475097
13 A>S No ClinGen
gnomAD
CA411475104
rs1256463707
13 A>V No ClinGen
TOPMed
rs970488362
CA324156231
14 Y>D No ClinGen
TOPMed
rs972790517
CA324156238
15 D>H No ClinGen
TOPMed
rs11551386
CA324156244
16 P>T No ClinGen
Ensembl
rs373682490
CA10226717
17 Y>* No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA10226714
rs751723535
17 Y>H No ClinGen
ExAC
gnomAD
rs757334226
CA10226715
17 Y>S No ClinGen
ExAC
gnomAD
rs1247722052
CA411475181
18 A>G No ClinGen
gnomAD
CA10226718
rs755985240
19 Y>H No ClinGen
ExAC
rs984408504
CA324156300
20 P>L No ClinGen
TOPMed
CA324156308
rs904848316
22 D>E No ClinGen
Ensembl
rs749029337
CA10226720
23 Y>C No ClinGen
ExAC
TOPMed
gnomAD
rs1311378746
CA411475305
25 M>L No ClinGen
TOPMed
rs200341537
CA324156310
25 M>R No ClinGen
ExAC
gnomAD
rs200341537
CA10226721
25 M>T No ClinGen
ExAC
gnomAD
rs1347058676
CA411475367
28 G>R No ClinGen
gnomAD
CA10226758
rs753747792
32 Q>H No ClinGen
ExAC
gnomAD
rs570948690
CA10226761
33 D>E No ClinGen
1000Genomes
ExAC
gnomAD
CA10226760
rs754895073
33 D>G No ClinGen
ExAC
TOPMed
gnomAD
CA10226759
rs754895073
33 D>V No ClinGen
ExAC
TOPMed
gnomAD
CA411475941
rs1375362523
34 L>F No ClinGen
TOPMed
rs777584086
CA10226763
37 E>A No ClinGen
ExAC
gnomAD
CA10226764
rs746606263
38 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs756749787
CA10226765
38 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA411476012
rs1322115505
39 Q>H No ClinGen
gnomAD
rs780707552
CA10226767
43 Q>H No ClinGen
ExAC
TOPMed
gnomAD
CA411476072
rs1569109218
44 T>A No ClinGen
Ensembl
rs139321489
CA10226768
44 T>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs139321489
CA10226769
44 T>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs748495579
CA10226770
46 Q>H No ClinGen
ExAC
gnomAD
CA411476105
rs1167243519
46 Q>P No ClinGen
gnomAD
CA324157299
rs746983707
49 P>L No ClinGen
Ensembl
rs538389346
CA324157303
57 Q>H No ClinGen
1000Genomes
CA411476237
rs1358554564
57 Q>P No ClinGen
gnomAD
rs1053258240
CA324157305
59 F>L No ClinGen
Ensembl
rs773306642
CA10226772
60 H>Y No ClinGen
ExAC
gnomAD
TCGA novel 61 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs760908440
CA10226773
62 T>A No ClinGen
ExAC
gnomAD
rs144080891
CA10226774
65 D>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA324157334
rs11551392
69 Q>* No ClinGen
Ensembl
rs1249588648
CA411476368
69 Q>H No ClinGen
gnomAD
CA10226775
rs776750051
71 V>M No ClinGen
ExAC
gnomAD
rs1262510622
CA411476413
73 E>K No ClinGen
TOPMed
rs1216801994
CA411476434
74 L>R No ClinGen
TOPMed
rs1368727868
CA411476456
76 A>S No ClinGen
TOPMed
gnomAD
CA10226778
rs752625789
77 S>T No ClinGen
ExAC
gnomAD
rs1389427027
CA411476478
78 R>C No ClinGen
gnomAD
rs867466509
CA324157359
78 R>H No ClinGen
TOPMed
gnomAD
CA411476479
rs867466509
78 R>L No ClinGen
TOPMed
gnomAD
CA411476506
rs1323155810
81 S>I No ClinGen
gnomAD
CA10226779
rs762848768
83 V>A No ClinGen
ExAC
gnomAD
CA411476520
rs1386896327
83 V>L No ClinGen
gnomAD
rs1293834308
CA411476531
84 I>T No ClinGen
TOPMed
rs763941591
CA10226780
89 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA411476581
rs1290072924
90 E>Q No ClinGen
TOPMed
rs1342538260
CA411476608
93 D>N No ClinGen
TOPMed
gnomAD
rs140860349
CA10226781
94 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs756916168
CA10226782
95 Y>C No ClinGen
ExAC
gnomAD
CA411476640
rs9610856
95 Y>D No ClinGen
gnomAD
CA324157375
rs9610856
95 Y>H No ClinGen
gnomAD
rs1270000216
CA411476668
96 E>D No ClinGen
gnomAD
rs971445833
CA324157430
98 S>T No ClinGen
TOPMed
rs779494865
CA10226808
101 K>E No ClinGen
ExAC
gnomAD
CA411477792
rs1279132250
101 K>M No ClinGen
TOPMed
gnomAD
CA411477790
rs1279132250
101 K>R No ClinGen
TOPMed
gnomAD
CA411477810
rs1178274985
103 T>A No ClinGen
TOPMed
rs1206886812
CA411477913
107 F>L No ClinGen
gnomAD
rs768005783
CA324160291
108 K>R No ClinGen
TOPMed
CA411477966
rs1256536218
110 T>I No ClinGen
TOPMed
rs1324483574
CA411477984
111 P>L No ClinGen
TOPMed
TCGA novel 111 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs145460534
CA10226811
116 E>V No ClinGen
ESP
ExAC
CA324160321
rs112260260
117 A>D No ClinGen
ESP
ExAC
TOPMed
CA10226812
rs112260260
117 A>V No ClinGen
ESP
ExAC
TOPMed
rs781481791
CA10226814
118 I>V No ClinGen
ExAC
gnomAD
rs1431783626
CA411478166
122 V>I No ClinGen
gnomAD
CA10226815
rs201545819
124 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs1054143991
CA324162740
125 D>G No ClinGen
Ensembl
CA411479635
rs1325155264
126 A>T No ClinGen
gnomAD
CA324162741
rs558967675
126 A>V No ClinGen
TOPMed
gnomAD
TCGA novel 128 F>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1360782647
CA411480033
137 Y>C No ClinGen
gnomAD
CA411480054
rs1314162303
138 R>K No ClinGen
TOPMed
gnomAD
rs1319417187
CA411480120
139 H>R No ClinGen
gnomAD
CA10226832
rs746143326
140 I>M No ClinGen
ExAC
TOPMed
gnomAD
rs781364202
CA10226831
140 I>T No ClinGen
ExAC
gnomAD
rs1233200053
CA411480131
140 I>V No ClinGen
gnomAD
rs756377025
CA10226833
141 Y>H No ClinGen
ExAC
TOPMed
gnomAD
rs1341086515
CA411480235
144 V>I No ClinGen
gnomAD
rs780350771
CA10226834
145 S>N No ClinGen
ExAC
TOPMed
gnomAD
rs759062483
CA10226870
146 G>E Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA324165406
rs898806054
147 G>R No ClinGen
Ensembl
CA10226872
rs774832603
160 Y>C No ClinGen
ExAC
gnomAD
rs768127139
CA10226875
162 N>K No ClinGen
ExAC
rs1221333229
CA411481891
162 N>S No ClinGen
gnomAD
rs750906417
CA10226878
165 N>S No ClinGen
ExAC
gnomAD
rs761129339
CA10226879
166 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA411482056
rs1206144941
167 I>V No ClinGen
gnomAD
rs779963254
CA10226896
171 D>N No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 172 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1391673078
CA411482297
173 P>S No ClinGen
gnomAD
rs768219088
CA10226898
174 A>T No ClinGen
ExAC
gnomAD
rs1325453450
CA411482329
175 P>A No ClinGen
TOPMed
rs1166755170
CA411482344
176 L>V No ClinGen
gnomAD
rs751540875
CA324165595
181 Q>R No ClinGen
Ensembl
CA324165600
rs754708343
182 W>C No ClinGen
Ensembl
rs960311047
CA324165608
184 W>C No ClinGen
TOPMed
gnomAD
rs989303246
CA324165611
186 I>V No ClinGen
gnomAD
rs151317788
CA411482648
187 I>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1394201099
CA411482645
187 I>T No ClinGen
gnomAD
rs763139923
CA10226925
201 R>C No ClinGen
ExAC
gnomAD
rs764198672
CA10226926
201 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1473168458
CA411485943
202 C>R No ClinGen
TOPMed
gnomAD
rs1473168458
CA411485946
202 C>S No ClinGen
TOPMed
gnomAD
rs1162023923
CA411485962
203 K>E No ClinGen
gnomAD
rs201168565
CA324172998
203 K>R No ClinGen
1000Genomes
TCGA novel 206 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1362406495
CA411486025
207 K>M No ClinGen
gnomAD
rs772818107
CA10226927
208 S>A No ClinGen
ExAC
gnomAD
rs1404679381
CA411486064
211 E>V No ClinGen
gnomAD
rs141774718
CA10226928
212 I>T No ClinGen
ESP
ExAC
gnomAD
rs1212290512
CA411486083
214 F>L No ClinGen
TOPMed
CA10226929
rs767371369
216 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA10226930
rs750311863
216 R>H No ClinGen
ExAC
gnomAD
rs1382333228
CA411486125
218 N>S No ClinGen
TOPMed
gnomAD
TCGA novel 222 W>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA10226931
rs755896770
222 W>G No ClinGen
ExAC
gnomAD
rs867982609
CA324173025
228 L>F No ClinGen
Ensembl
CA10226932
rs373478865
229 N>S No ClinGen
ESP
ExAC
gnomAD
rs1324741179
CA411486280
230 V>I No ClinGen
gnomAD
rs762861946
CA324173051
235 V>I No ClinGen
Ensembl
rs1010279745
CA324173072
239 N>S No ClinGen
gnomAD
CA10226936
rs747646009
241 N>T No ClinGen
ExAC
rs1325088474
CA411486425
242 R>* No ClinGen
TOPMed
CA10226937
rs771550369
242 R>Q No ClinGen
ExAC
gnomAD
rs1278920982
CA411486436
243 Q>R No ClinGen
gnomAD
CA324173087
rs966609633
246 V>A No ClinGen
gnomAD
rs1379761675
CA411486550
250 G>R No ClinGen
TOPMed
gnomAD
CA10226965
rs773307510
255 S>G No ClinGen
ExAC
gnomAD
CA10226966
rs760592109
259 E>G No ClinGen
ExAC
gnomAD
rs1163626581
CA411487207
260 Y>C No ClinGen
TOPMed
gnomAD
rs1246147122
CA411487204
260 Y>D No ClinGen
gnomAD
CA411487222
rs766324137
262 R>G No ClinGen
ExAC
gnomAD
CA10226968
rs150200232
262 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA10226969
rs150200232
262 R>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA324175721
rs150200232
262 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs766324137
CA10226967
262 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA411487231
rs1213407855
263 H>R No ClinGen
gnomAD
CA411487265
rs1486935270
266 Y>C No ClinGen
gnomAD
rs1406637319
CA411487304
269 L>F No ClinGen
TOPMed
rs758047383
CA10226972
276 G>R No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 277 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA411487400
rs1163890297
278 L>F No ClinGen
gnomAD
rs1432384069
CA411487413
279 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs149341352
CA10226976
281 H>Q No ClinGen
ESP
ExAC
rs202247175
CA10226975
281 H>R No ClinGen
1000Genomes
ExAC
gnomAD
rs1372967848
CA411487442
282 S>Y No ClinGen
gnomAD
rs769034639
CA10226979
286 D>V No ClinGen
ExAC
gnomAD
CA411487545
rs1333282431
290 A>G No ClinGen
gnomAD
TCGA novel 291 I>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs772330883
CA10226982
292 K>R No ClinGen
ExAC
TOPMed
gnomAD
CA411487685
rs1241781804
297 I>V No ClinGen
gnomAD
CA411487704
rs760820592
298 E>* No ClinGen
ExAC
gnomAD
CA10226984
rs760820592
298 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA411487778
rs1255530299
301 K>Q No ClinGen
gnomAD
CA10226985
rs771066209
302 K>N No ClinGen
ExAC
CA10227004
rs745840459
304 M>I No ClinGen
ExAC
gnomAD
rs536981260
CA10227003
304 M>R No ClinGen
1000Genomes
ExAC
gnomAD
rs554941299
CA10227005
311 C>R No ClinGen
1000Genomes
ExAC
gnomAD
CA10227008
rs763759372
317 Y>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA324176357
rs1000404223
317 Y>H No ClinGen
TOPMed
CA10227010
rs371837127
320 G>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA10227011
rs767058832
322 A>G No ClinGen
ExAC
gnomAD
CA411488901
rs1205899248
327 R>C No ClinGen
gnomAD
rs1205899248
CA411488897
327 R>G No ClinGen
gnomAD
CA324176362
rs376536658
327 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
gnomAD
CA10227013
rs376536658
327 R>P No ClinGen
ESP
ExAC
gnomAD
rs1439422406
CA411488934
328 R>C No ClinGen
gnomAD
rs765784918
CA10227014
328 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
rs1210746382
CA411488970
329 Y>C No ClinGen
TOPMed
CA324176378
rs11551380
330 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs1462562496
CA411489035
331 D>Y No ClinGen
gnomAD
rs777949481
CA10227017
334 R>Q No ClinGen
ExAC
gnomAD
rs1453440089
CA411489169
337 A>S No ClinGen
TOPMed
gnomAD
CA411489167
rs1453440089
337 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA10227019
rs757521283
338 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs1408652952
CA411489288
340 L>F No ClinGen
gnomAD
CA324176394
rs2899294
341 L>I No ClinGen
Ensembl
rs1353582438
CA411489401
343 I>V No ClinGen
gnomAD
rs1443621132
CA411489571
347 K>T No ClinGen
gnomAD
CA10227026
rs773983015
349 M>V No ClinGen
ExAC
gnomAD
rs1229418067
CA411489744
350 F>I No ClinGen
TOPMed
gnomAD
CA411489841
rs1271947489
351 Q>L No ClinGen
gnomAD
CA411489838
rs1271947489
351 Q>R No ClinGen
gnomAD
rs142568173
CA10227028
353 T>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1272258341
CA411489946
354 T>M No ClinGen
gnomAD
rs1215276616
CA411489989
355 Y>F No ClinGen
gnomAD
TCGA novel 358 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA411490149
rs765769337
359 M>L No ClinGen
ExAC
TOPMed
gnomAD
CA10227031
rs765769337
359 M>V No ClinGen
ExAC
TOPMed
gnomAD
rs1569121907
CA411491666
362 K>R No ClinGen
Ensembl
rs764522830
CA10227053
366 Q>R No ClinGen
ExAC
gnomAD
rs1400371009
CA411491886
368 H>N No ClinGen
gnomAD
rs762298655
CA411491927
369 A>E No ClinGen
ExAC
TOPMed
gnomAD
rs762298655
CA10227055
369 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA411492019
rs1197634723
372 A>V No ClinGen
TOPMed
rs756257327
CA10227058
374 A>V No ClinGen
ExAC
gnomAD
CA324177293
rs990003683
376 T>M No ClinGen
TOPMed
CA10227060
rs777349139
377 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA10227063
rs748041513
380 M>I No ClinGen
ExAC
gnomAD
CA10227062
rs778830324
380 M>T No ClinGen
ExAC
gnomAD
rs771878433
CA10227064
381 R>C No ClinGen
ExAC
gnomAD
CA10227065
rs777523428
381 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA411492357
rs9466
382 I>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA10227066
rs746705075
382 I>T No ClinGen
ExAC
gnomAD
CA10227068
rs776263130
385 S>G No ClinGen
ExAC
gnomAD
TCGA novel 385 S>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs373585941
CA10227071
390 L>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1320953795
CA411492603
391 R>Q No ClinGen
TOPMed
rs1310968870
CA411492591
391 R>W Variant assessed as Somatic; 4.62e-05 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1397782392
CA411492824
398 M>I No ClinGen
TOPMed
CA10227073
rs768031159
398 M>V No ClinGen
ExAC
gnomAD
CA10227074
rs773704624
400 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
rs761011952
CA10227075
400 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs761011952
CA324177325
400 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs1428435563
CA411493054
406 P>S No ClinGen
TOPMed
rs369601340
CA10227077
407 Q>P No ClinGen
ExAC
TOPMed
gnomAD
CA411493135
rs1434523793
409 Y>H No ClinGen
gnomAD
CA411493343
rs1279037565
414 S>N No ClinGen
gnomAD
rs765254322
CA10227081
416 S>F No ClinGen
ExAC
gnomAD
rs11551383
CA324177347
417 C>S No ClinGen
Ensembl
TCGA novel 420 F>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1452832290
CA411493606
422 S>L No ClinGen
gnomAD
TCGA novel 423 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA10227083
rs758301717
424 V>I No ClinGen
ExAC
TOPMed
gnomAD
CA10227084
rs777613122
427 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA324177363
rs774785447
428 Y>C No ClinGen
TOPMed
CA411493735
rs1394026205
428 Y>H No ClinGen
gnomAD
CA10227085
rs746766954
430 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs746766954
CA411493805
430 N>T No ClinGen
ExAC
TOPMed
gnomAD
CA324177376
rs907744137
431 V>A No ClinGen
TOPMed
CA10227086
rs757010146
431 V>M No ClinGen
ExAC
gnomAD
CA411493845
rs780737692
432 H>P No ClinGen
ExAC
CA411493848
rs1366402645
432 H>Q No ClinGen
TOPMed
CA10227087
rs780737692
432 H>R No ClinGen
ExAC
rs745473648
CA10227088
433 P>S No ClinGen
ExAC
gnomAD
rs769475626
CA10227089
434 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs748727702
CA10227091
436 H>Q No ClinGen
ExAC
gnomAD
CA10227092
rs772689759
437 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs773792708
CA10227093
438 E>Q No ClinGen
ExAC
CA411494029
rs1327666008
439 P>S No ClinGen
TOPMed
rs760956614
CA10227094
440 F>L No ClinGen
ExAC
gnomAD
CA411494048
rs1408530155
440 F>V No ClinGen
TOPMed
rs933103404
CA324177385
444 L>P No ClinGen
Ensembl
CA324177393
rs538134982
448 S>P No ClinGen
1000Genomes
TOPMed
gnomAD
CA411494261
rs1423558558
450 E>A No ClinGen
TOPMed
CA411494249
rs1569122167
450 E>K No ClinGen
Ensembl
rs1255322591
CA411494276
451 V>I No ClinGen
TOPMed
gnomAD
rs547479833
CA324177399
456 Q>H No ClinGen
Ensembl
CA10227097
rs759785314
458 S>L No ClinGen
ExAC
gnomAD
CA411494416
rs1482001559
458 S>P No ClinGen
TOPMed
rs765342369
CA10227098
460 I>V No ClinGen
ExAC
gnomAD
rs1012145731
CA324177411
461 R>H No ClinGen
TOPMed
CA411494560
rs1371217170
465 K>N No ClinGen
gnomAD
rs757960234
CA10227100
465 K>R No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 467 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA411494700
rs1459541368
471 P>L No ClinGen
gnomAD
CA411494771
rs1601779027
474 K>R No ClinGen
Ensembl
rs1292657056
CA411494858
477 G>D No ClinGen
gnomAD
rs377263699
CA10227103
480 D>H No ClinGen
ESP
ExAC
TOPMed
rs1357860721
CA411494969
482 T>R No ClinGen
TOPMed
CA411495027
rs1292853457
485 E>D No ClinGen
gnomAD
CA10227105
rs781017938
487 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs903452935
CA411495058
487 R>W No ClinGen
gnomAD
TCGA novel 490 L>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1221067811
CA411495229
494 K>R No ClinGen
TOPMed
gnomAD
rs1390431733
CA411495248
495 H>P No ClinGen
TOPMed
gnomAD
rs768210839
CA10227110
501 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA324177451
rs62235091
503 T>N No ClinGen
Ensembl
CA411495449
rs1601779098
504 S>G No ClinGen
Ensembl
rs771251436
CA10227113
505 G>S No ClinGen
ExAC
gnomAD
CA411495519
rs1419760525
506 I>N No ClinGen
gnomAD
TCGA novel 507 S>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA324177460
rs960022400
508 A>S No ClinGen
TOPMed
gnomAD
CA10227115
rs759745071
510 D>G No ClinGen
ExAC
TOPMed
gnomAD
rs762130059
CA324177465
511 G>D No ClinGen
Ensembl
rs1397422252
CA411495715
516 A>S No ClinGen
gnomAD
rs1359363864
CA411495770
519 V>A No ClinGen
gnomAD
CA10227117
rs769991141
519 V>F No ClinGen
ExAC
gnomAD
rs769991141
CA10227116
519 V>I No ClinGen
ExAC
gnomAD
CA10227118
rs763051302
522 Y>C No ClinGen
ExAC
TOPMed
gnomAD
rs1295694711
CA411495842
523 I>F No ClinGen
gnomAD
CA10227119
rs764111523
523 I>T No ClinGen
ExAC
gnomAD
CA411495894
rs1601779197
524 D>G No ClinGen
Ensembl
rs1422456529
CA411498494
529 H>R No ClinGen
gnomAD
rs201577615
CA324181904
531 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs774028718
CA10227145
531 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA10227149
rs765907943
536 A>S No ClinGen
ExAC
gnomAD
CA10227148
rs765907943
536 A>T No ClinGen
ExAC
gnomAD
rs781724982
CA411498594
538 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs781724982
CA10227150
538 R>P No ClinGen
ExAC
TOPMed
gnomAD
rs1301917300
CA752989498
539 Y>* No ClinGen
TOPMed
CA411498695
rs1273687830
547 I>N No ClinGen
gnomAD
rs749577319
CA10227154
549 K>R No ClinGen
ExAC
gnomAD
CA411498758
rs1196481919
552 E>D Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs756695456
CA10227197
554 N>D No ClinGen
ExAC
TOPMed
gnomAD
CA10227198
rs368635683
555 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs755388764
CA10227200
559 K>E No ClinGen
ExAC
gnomAD
CA411499590
rs1463765686
560 M>L No ClinGen
TOPMed
CA411499622
rs1231667754
562 Q>* No ClinGen
gnomAD
CA324182891
rs965546316
564 P>A No ClinGen
TOPMed
CA324182915
rs199910157
564 P>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs199910157
CA10227201
564 P>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs965546316
CA411499654
564 P>T No ClinGen
TOPMed
rs748446114
CA10227202
565 P>G No ClinGen
ExAC
gnomAD

No associated diseases with Q9Y262

1 regional properties for Q9Y262

Type Name Position InterPro Accession
domain Proteasome component (PCI) domain 331 - 537 IPR000717

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

7 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
eukaryotic 43S preinitiation complex A protein complex composed of the 40S ribosomal subunit plus eIF1A, eIF3, and eIF2-GTP-bound methionyl-initiator methionine tRNA.
eukaryotic 48S preinitiation complex A protein complex composed of the small ribosomal subunit, eIF3, eIF1A, methionyl-initiatior methionine and a capped mRNA. The complex is initially positioned at the 5'-end of the capped mRNA.
eukaryotic translation initiation factor 3 complex A complex of several polypeptides that plays at least two important roles in protein synthesis: First, eIF3 binds to the 40S ribosome and facilitates loading of the Met-tRNA/eIF2.GTP ternary complex to form the 43S preinitiation complex. Subsequently, eIF3 apparently assists eIF4 in recruiting mRNAs to the 43S complex. The eIF3 complex contains five conserved core subunits, and may contain several additional proteins; the non-core subunits are thought to mediate association of the complex with specific sets of mRNAs.
fibrillar center A structure found most metazoan nucleoli, but not usually found in lower eukaryotes; surrounded by the dense fibrillar component; the zone of transcription from multiple copies of the pre-rRNA genes is in the border region between these two structures.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.

2 GO annotations of molecular function

Name Definition
RNA binding Binding to an RNA molecule or a portion thereof.
translation initiation factor activity Functions in the initiation of ribosome-mediated translation of mRNA into a polypeptide.

3 GO annotations of biological process

Name Definition
formation of cytoplasmic translation initiation complex Joining of the large subunit, with release of IF2/eIF2 and IF3/eIF3. This leaves the functional ribosome at the AUG, with the methionyl/formyl-methionyl-tRNA positioned at the P site.
translational initiation The process preceding formation of the peptide bond between the first two amino acids of a protein. This includes the formation of a complex of the ribosome, mRNA or circRNA, and an initiation complex that contains the first aminoacyl-tRNA.
viral translational termination-reinitiation A process which occurs as part of viral mRNA translation which allows expression of a downstream open reading frame (ORF) in a dicistronic mRNA. In this process, ribosomes translate the upstream ORF but following termination, a proportion of 40S subunits remain tethered to the mRNA and go on to re-initiate translation at the start codon of the downstream ORF.

6 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q3ZCK1 EIF3L Eukaryotic translation initiation factor 3 subunit L Bos taurus (Bovine) PR
Q5F428 EIF3L Eukaryotic translation initiation factor 3 subunit L Gallus gallus (Chicken) PR
A5A6M4 EIF3L Eukaryotic translation initiation factor 3 subunit L Pan troglodytes (Chimpanzee) PR
Q8QZY1 Eif3l Eukaryotic translation initiation factor 3 subunit L Mus musculus (Mouse) PR
Q6P878 eif3l Eukaryotic translation initiation factor 3 subunit L Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
Q7T2A5 eif3l Eukaryotic translation initiation factor 3 subunit L Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MSYPADDYES EAAYDPYAYP SDYDMHTGDP KQDLAYERQY EQQTYQVIPE VIKNFIQYFH
70 80 90 100 110 120
KTVSDLIDQK VYELQASRVS SDVIDQKVYE IQDIYENSWT KLTERFFKNT PWPEAEAIAP
130 140 150 160 170 180
QVGNDAVFLI LYKELYYRHI YAKVSGGPSL EQRFESYYNY CNLFNYILNA DGPAPLELPN
190 200 210 220 230 240
QWLWDIIDEF IYQFQSFSQY RCKTAKKSEE EIDFLRSNPK IWNVHSVLNV LHSLVDKSNI
250 260 270 280 290 300
NRQLEVYTSG GDPESVAGEY GRHSLYKMLG YFSLVGLLRL HSLLGDYYQA IKVLENIELN
310 320 330 340 350 360
KKSMYSRVPE CQVTTYYYVG FAYLMMRRYQ DAIRVFANIL LYIQRTKSMF QRTTYKYEMI
370 380 390 400 410 420
NKQNEQMHAL LAIALTMYPM RIDESIHLQL REKYGDKMLR MQKGDPQVYE ELFSYSCPKF
430 440 450 460 470 480
LSPVVPNYDN VHPNYHKEPF LQQLKVFSDE VQQQAQLSTI RSFLKLYTTM PVAKLAGFLD
490 500 510 520 530 540
LTEQEFRIQL LVFKHKMKNL VWTSGISALD GEFQSASEVD FYIDKDMIHI ADTKVARRYG
550 560
DFFIRQIHKF EELNRTLKKM GQRP